Comparison of pyruvate kinase variants from breast tumor and normal breast.

[1]  D. Duś,et al.  Pyruvate kinase inhibited by L-cysteine as a marker of tumorigenic human urothelial cell lines , 1989, Experientia.

[2]  C. Veelen,et al.  Discrimination between neuronal and glial cell tumours by pyruvate kinase electrophoresis , 2005, Acta Neurochirurgica.

[3]  C. Radzikowski,et al.  A pyruvate kinase variant in different mouse transplanted tumors , 1988, Experientia.

[4]  P. Roholl,et al.  Pyruvate kinase activity and isozyme composition in normal fibrous tissue and fibroblastic proliferations , 1991, Cancer.

[5]  J. Bueren,et al.  Kinetic studies of pyruvate kinase duringin vitro differentiation of GM-CFC haemopoietic precursor and bone marrow cells in mice , 1990, Bioscience reports.

[6]  P. Roholl,et al.  Characterization of pyruvate kinase from human rhabdomyosarcoma in relation to immunohistochemical and morphological criteria , 1989, Cancer.

[7]  B. V. van Oirschot,et al.  Heterogeneity of glycolytic enzyme activity and isozyme composition of pyruvate kinase in breast cancer. , 1988, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[8]  T. Tanaka,et al.  The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. , 1986, The Journal of biological chemistry.

[9]  M. Gumińska,et al.  The inhibitory effect of various fatty acids on aerobic glycolysis in Ehrlich ascites tumour cells. , 1986, Acta biochimica Polonica.

[10]  R. Beitner.  Regulation Of Carbohydrate Metabolism , 2018 .

[11]  G. Staal,et al.  Pyruvate kinase in normal human thyroid tissue and thyroid neoplasms , 1985, Cancer.

[12]  G. Staal,et al.  Pyruvate kinase isozymes and dedifferentiation of (neuro-)ectodermal tumors. , 1985, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[13]  D. Balinsky,et al.  Isozyme patterns of normal, benign, and malignant human breast tissues. , 1983, Cancer research.

[14]  M. Gumińska,et al.  The inhibitory effect of L-cysteine and its derivatives on glycolysis in Ehrlich ascites tumour cells. , 1983, Biochimica et biophysica acta.

[15]  M. Burt,et al.  Purine and pyrimidine enzymic programs and nucleotide pattern in sarcoma. , 1983, Cancer research.

[16]  D. Siemann,et al.  In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole. , 1983, Cancer research.

[17]  F. Beemer,et al.  Characterization of some glycolytic enzymes from human retina and retinoblastoma. , 1982, Cancer research.

[18]  S. Weinhouse.  What are isozymes telling us about gene regulation in cancer? , 1982, Journal of the National Cancer Institute.

[19]  R. Orlando,et al.  Expression of multimolecular forms of pyruvate kinase in normal, benign, and malignant human breast tissue. , 1982, Cancer research.

[20]  A. Kahn,et al.  Pyruvate Kinase and Phosphofructokinase Isozymes in Childhood Cancers , 1982, Pediatric Research.

[21]  Takehiko Tanaka,et al.  [25] Pyruvate kinase isozymes from rat , 1982 .

[22]  M. Gosálvez,et al.  Quantitative determination of the degree of differentiation of mammary tumors by pyruvate kinase kinetic analysis. , 1981, Cancer research.

[23]  C. V. van Veelen,et al.  L-alpha-alanine inhibition of pyruvate kinase from tumors of the human central nervous system. , 1979, Cancer research.

[24]  C. V. van Veelen,et al.  Isozymes of pyruvate kinase from human brain, meningiomas, and malignant gliomas. , 1978, Cancer research.

[25]  C. Rutherford,et al.  Application of a microchemical technique to the elucidation of enzyme activity profiles within single human mammary tumors , 1978, Cancer.

[26]  M. Gosálvez,et al.  Metabolic control of glycolysis in normal and tumor permeabilized cells. , 1978, Cancer research.

[27]  G. Weber.  Enzymology of cancer cells (second of two parts). , 1977, The New England journal of medicine.

[28]  G. Weber.  Enzymology of cancer cells (first of two parts). , 1977, The New England journal of medicine.

[29]  J. Kaplan,et al.  International Committee for Standardization in Haematology: Recommended Methods for Red‐Cell Enzyme Analysis * , 1977, British journal of haematology.

[30]  K. Ibsen.  Interrelationships and functions of the pyruvate kinase isozymes and their variant forms: a review. , 1977, Cancer research.

[31]  T. Warchol.  The influence of transplantable Morris hepatoma on the pentose-phosphate cycle in rat erythrocytes. , 1975, Annals of the Medical Section of the Polish Academy of Sciences.

[32]  K. Matsumura,et al.  Isozyme patterns of pyruvate kinase in various primary liver tumors induced during the process of hepatocarcinogenesis. , 1974, Cancer research.

[33]  S. Weinhouse,et al.  Isozymes of pyruvate kinase in liver and hepatomas of the rat. , 1974, Cancer research.

[34]  J. Wittliff,et al.  Studies on certain cytoplasmic enzymes and specific estrogen receptors in human breast cancer and in nonmalignant diseases of the breast. , 1973, Cancer research.

[35]  A. Sols,et al.  Pyruvate kinase. Classes of regulatory isoenzymes in mammalian tissues. , 1973, European journal of biochemistry.

[36]  F. Schapira.  Isozymes and cancer. , 1973, Advances in cancer research.

[37]  F. Schapira.  [Isoenzymes and cancer]. , 1970, Pathologie-biologie.

[38]  D. E. Atkinson.  The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. , 1968, Biochemistry.

[39]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.